位置:成果数据库 > 期刊 > 期刊详情页
高迁移率族蛋白B1对小鼠调节性T细胞表达T淋巴细胞毒性相关抗原-4水平的影响及受体机制
  • 期刊名称:中华实验外科杂志, 2009, 26(3): 312-314.
  • 时间:0
  • 分类:R581[医药卫生—内分泌;医药卫生—临床医学;医药卫生—内科学] R631.02[医药卫生—临床医学;医药卫生—外科学]
  • 作者机构:[1]解放军总医院第二附属医院肝胆外科,北京100091, [2]解放军总医院第一附属医院全军烧伤研究所
  • 相关基金:基金项目:国家自然科学基金资助项目(30672178,30872683,30800437);国家重点基础研究发展规划项目(2005CB522602)
  • 相关项目:高迁移率族蛋白B1的细胞免疫效应及其在烧伤脓毒症中的作用
中文摘要:

目的观察高迁移率族蛋白B1(HMGB1)对小鼠调节性T细胞(Treg)表达细胞毒性T淋巴细胞相关抗原(CTLA)-4水平的影响及其受体机制。方法免疫磁珠法分离正常C3H/HeN[(Toll样受体4(TLR4)野生型)]小鼠脾脏CD4+CD25+Treg,接种于细胞培养板,各细胞培养孔均加入可溶性抗CD3和可溶性抗CD28作为辅助活化剂。应用/不应用抗TLR4抗体预封闭CD4+CD25+Treg表面TLR4,观察HMGB1刺激CD4+CD25+Treg表达CTLA-4的时间.效应关系和剂量-效应关系。结果HMGB1(0.1mg/L)刺激CIM+CD25+Treg,cTLA-4在24、48、72h表达水平(47.56±5.49、35.83±4.96和31.94±4.65)较正常对照组水平(79.42±2.79)均显著下降(P〈0.01),以48、72h组下降尤为明显;不同剂量HMGB1刺激CD4+CD25+Treg48h其CTLA-4表达水平显著下调(P〈0.01),其中以0.1mg/L和1mg/L组表达水平(分别为33.34±4.00和29.90±4.30)降低幅度尤为明显。经封闭TLR4预处理后,给予HMGB1(0.1mg/L)刺激24、48和72hCD4+CD25+Treg表达CTLA-4的水平(90.39±8.80、93.13±4.80和80.29±4.31)均较对正常照组(71.03±4.34)显著增强(P〈0.05或P〈0.01);而不同剂量HMGB1刺激CD4+CD25+Treg48h,仅以0.1mg/L组能显著上调CTLA-4的表达水平(P〈0.01)。结论HMGB1通过TLR4负向调节CD4+CD25+Treg表达CTLA-4水平,从而影响Treg的免疫活性。

英文摘要:

Objective To investigate the effect of high mobility group box-1 protein (HMGB1) on the expression of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) in regulatory T cells (Treg) and its potential receptor mechanism in mice. Methods CD4+ CD25+ Tregs isolated from the spleens of C3H/HeN [ Toll-like receptor 4 (TLR4) wild type l mice by magnetic beads were seeded on 96-well cell culture plates coated with 1 mg/L anti-CD3 and soluble CD28. By treatment with or without anti-mouse TLR4 antibody ,the time-and dose-dependent responses between HMGB1 stimulation and CTLA-4 expression on CD4 + CD25 + Tregs were studied. Results Compared to normal controls, the expression of CTLA-4 on CIM + CD25+ Tregs stimulated by 0.1 mg/L HMGB1 was significantly down-regulated at 24,48 ,and 72 h (47.56 ±5.49,35.83 ±4.96,and 31.94 ±4.65 ,respectively) ( all P 〈0.01 ) ,especially at 48 and 72 h. Meanwhile, markedly decreased expression of CTLA-4 was found CD4+CD25 + Tregs treated with HMGB1 at various concentrations (0.01,0.1 and 1 rag/L) for 48 h (58.87 ± 6.70,33.34 ±4.00 and 29.90 ±4.30, respectively, all P 〈 0.01 ). After pretreatment with TLR4 antibody, however, the CTLA-4 expression on CD4+ CD25 + Tregs was significantly enhanced by HMGB1 (0.1 mg/L) stimulation at 24,48 and 72 h (90.39 ± 8.80,93.13±4.80 and 80.29 ± 4.31, respectively, P 〈 0.05 or P 〈 0.01 ). After treatment with different doses of HMGB1 for 48 h ,the CTLA-4 expression on CD4 + CD25 + Tregs was much higher in 0.1 mg/L HMGB1 group (94.98 ± 6.35 ) than in normal controls ( P 〈 0.01 ). Conclusion With HMGB1 stimulation,TLR4 can markedly down-regulate CTLA-4 expression levels on CD4+ CD25 + Tregs, thereby influencing the immunological activity of Tregs.

同期刊论文项目
同项目期刊论文